Liver Cancer | Tumor

Pediatric Liver Cancer Cases Have Increased Over Last 30 Years

January 12th 2021, 7:00pm


Over the last 30 years, cases of childhood liver cancer have increased in the United States, Australia and a Canadian province.

5 Liver Cancer News and Updates That Patients May Have Missed in 2020

January 7th 2021, 2:00pm


A roundup of liver cancer news and updates that occurred in 2020 patients with cancer may have missed.

What Patients with Cholangiocarcinoma Should Be Prepared for When Joining a Trial

December 17th 2020, 9:04pm


A clinical research coordinator discusses how patients with cholangiocarcinoma can get involved in clinical trials, such as the phase 3 PROOF trial, as well as what they should know once they are enrolled.

Making Art From Cancer

December 10th 2020, 4:00pm


This week on the “CURE® Talks Cancer” podcast, we spoke with renowned street artist James Cochran about one of his art projects that was commissioned to symbolize the creativity and commitment of those who work tirelessly to eradicate cancer.

When Art Meets Cancer Science

December 9th 2020, 4:00pm


Street artist James Cochran gives CURE® an inside look at his newest project: a piece of art he created by applying 50,000 small dots of paint to a canvas using a lab pipette. It will be displayed in the Institute of Cancer Research’s Centre for Cancer Drug Discovery as a symbol of the creativity and commitment of the scientists who work every day to eradicate cancer.

Patients with HCC Positively Respond to Opdivo with Yervoy When Nexavar Was Not an Option

November 2nd 2020, 10:00pm


Results of this trial led to an accelerated FDA approval of Opdivo (nivolumab) and Yervoy (ipilimumab) in March to treat this specific patient population.

Patients with Unresectable HCC Lived Longer When Given Hepatic Arterial Infusion Chemotherapy Versus Standard of Care

October 6th 2020, 1:00pm


Overall survival was better with hepatic arterial infusion chemotherapy compared with transarterial chemoembolization, according to phase 3 study findings.

Younger Adults, Women with Cancer Respond Less Well to Immunotherapy with Checkpoint Inhibitors

September 16th 2020, 1:00pm


Younger and female patients with a variety of cancer types tend to have strong immune systems that naturally fight an array of cancer cells. The tumor cells the immune system doesn’t destroy are the most evasive, both to the immune system and medications that boost its activity, and this makes checkpoint inhibitor immunotherapy less effective in this population.

Two-Drug Combination Could Provide Benefits for Cholangiocarcinoma Subset

August 25th 2020, 1:00pm


At a median follow-up of 10 months, all patients who received Tafinlar plus Mekinist achieved an overall response rate of 51%.

Can Collaboration Help Find A Cure for Cholangiocarcinoma?

August 22nd 2020, 2:00pm


Could paradigm shifts in cancer research help find a cure for cholangiocarcinoma? Experts discuss.